Skip to main content
Clinical Trials/CTRI/2018/08/015161
CTRI/2018/08/015161
Not yet recruiting
Phase 4

Study of efficacy and safety of Intravenous Paracetamol Infusion as intrapartum analgesic: Randomized Control Trial

CRH Sikkim Manipal Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
CRH Sikkim Manipal Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
CRH Sikkim Manipal Institute of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\.Age between 18\-35 years.
  • 2\.Primigravida and multigravida
  • 3\.The gestational age between 37\- 42 weeks.
  • 4\.Patient seeking analgesia.
  • 5\.Single viable fetus.
  • 6\.Vertex presentation.
  • 7\.1st stage of labour with cervical dilatation 3\-4 cm (in active phase).

Exclusion Criteria

  • 1\.Extreme of age (below 18\-above 35\).
  • 2\.Multiple gestation.
  • 3\.Malpresentation.
  • 4\.Major degree of cephalopelvic disproportion.
  • 5\.Any medical disorder with pregnancy e.g., Rheumatic heart disease, Diabetes mellitus, Hypertension.
  • 6\.Use of any other kind of analgesia before recruitment in the study
  • 7\.Scared uterus.
  • 8\.Fetal distress.
  • 9\.Antepartum hemorrhage.
  • 10\.Polyhydramnios.

Outcomes

Primary Outcomes

Not specified

Similar Trials